<DOC>
	<DOCNO>NCT01240161</DOCNO>
	<brief_summary>The central hypothesis proposal multimodal ( clinical , image , tissue ) biomarkers well predict early brain tumor response treatment reliable prognostic marker patient malignant brain tumor .</brief_summary>
	<brief_title>Personalized Translational Platform Biomarker Discovery Brain Tumors</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Newly diagnose suspect high grade glioma ≥ 1cm diameter postoperative anatomic imaging ( contrast MRI ) , prior initiation chemoXRT Anticipated survival ≥6 month Able give inform consent Capable undergoing MRI PET scan without need sedation general anesthesia Male Female Prior radiation therapy chemotherapy brain Active intracranial infection nonglial brain mass . Recent large intracranial hemorrhage ( &lt; 1 month ) Expected survival &lt; 6 month Pregnant nursing Renal failure Lives far BWH and/or unwilling/ unable return schedule image visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Glioblastoma multiforme</keyword>
	<keyword>FLT</keyword>
	<keyword>PET</keyword>
</DOC>